Voyageur Pharmaceuticals (CVE:VM) Shares Up 21.1% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price traded up 21.1% on Friday . The company traded as high as C$0.12 and last traded at C$0.12. 710,813 shares changed hands during mid-day trading, an increase of 344% from the average session volume of 160,239 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 47.4 %

The stock has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The stock’s 50 day moving average price is C$0.08 and its 200-day moving average price is C$0.06. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.